Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)”

513 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 513 results

Testing effectiveness (Phase 2)UnknownNCT02639858
What this trial is testing

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Samyang Biopharmaceuticals Corporation 31
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Looking for participantsNCT07423078
What this trial is testing

Window of Opportunity in Preserving Laryngeal Function Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
Matthew Spector 87
Early research (Phase 1)WithdrawnNCT06357858
What this trial is testing

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01602315
What this trial is testing

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Novartis Pharmaceuticals 179
Testing effectiveness (Phase 2)Study completedNCT00033618
What this trial is testing

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+31 more
National Cancer Institute (NCI) 144
Large-scale testing (Phase 3)Study completedNCT05802290
What this trial is testing

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Gruppo Oncologico del Nord-Ovest 124
Not applicableStudy completedNCT01466244
What this trial is testing

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07679997
What this trial is testing

Trilaciclib Combined With Immunochemotherapy for R/M HNSCC

Who this might be right for
Head & Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32
Testing effectiveness (Phase 2)Ended earlyNCT01285635
What this trial is testing

AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
University of Michigan Rogel Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00006471
What this trial is testing

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT00589667
What this trial is testing

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01133665
What this trial is testing

Cetuximab and Lenalidomide in Head and Neck

Who this might be right for
Squamous Cell Carcinoma
University of Chicago 42
Not applicableStudy completedNCT01466257
What this trial is testing

Biomarkers in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 70
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT07040072
What this trial is testing

Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC

Who this might be right for
HNSCC
Beijing Tongren Hospital 10
Testing effectiveness (Phase 2)Study completedNCT05156970
What this trial is testing

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Not applicableLooking for participantsNCT06061705
What this trial is testing

Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Fondation Hôpital Saint-Joseph 100
Testing effectiveness (Phase 2)Study completedNCT00815295
What this trial is testing

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Who this might be right for
Squamous Cell Cancer
Duke University 31
Next Page